Phathom Pharmaceuticals Non-GAAP EPS of -$0.08 beats by $0.11, revenue of $57.6M beats by $0.16M
Source: SeekingAlpha
2026-02-26 07:20:17 ET
More on Phathom Pharmaceuticals
- Phathom: Why I'm Not Buying The Dip (Yet)
- Phathom Pharmaceuticals Q4 2025 Earnings Preview
- Phathom slumps 12%; prices $130M stock at $16 per share
- Seeking Alpha’s Quant Rating on Phathom Pharmaceuticals
- Historical earnings data for Phathom Pharmaceuticals
Read the full article on Seeking Alpha
For further details see:
Phathom Pharmaceuticals Non-GAAP EPS of -$0.08 beats by $0.11, revenue of $57.6M beats by $0.16M
Phathom Pharmaceuticals Inc.
NASDAQ: PHAT
PHAT Trading
7.36% G/L:
$11.09 Last:
269,380 Volume:
$10.50 Open:
PHAT Latest News
February 26, 2026 07:00:00 am
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
PHAT Stock Data
$1,007,653,754
60,286,977
0.48%
62
N/A
Biotechnology & Life Sciences
Healthcare
US
Florham Park
